IBDEI0MH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11005,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,11005,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,11005,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,11006,0)
 ;;=590.10^^64^692^46
 ;;^UTILITY(U,$J,358.3,11006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11006,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,11006,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,11006,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,11007,0)
 ;;=590.00^^64^692^47
 ;;^UTILITY(U,$J,358.3,11007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11007,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,11007,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,11007,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,11008,0)
 ;;=788.7^^64^692^54
 ;;^UTILITY(U,$J,358.3,11008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11008,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,11008,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,11008,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,11009,0)
 ;;=131.02^^64^692^57
 ;;^UTILITY(U,$J,358.3,11009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11009,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,11009,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,11009,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,11010,0)
 ;;=597.80^^64^692^55
 ;;^UTILITY(U,$J,358.3,11010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11010,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,11010,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,11010,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,11011,0)
 ;;=788.41^^64^692^58
 ;;^UTILITY(U,$J,358.3,11011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11011,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,11011,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,11011,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,11012,0)
 ;;=788.31^^64^692^62
 ;;^UTILITY(U,$J,358.3,11012,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11012,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,11012,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,11012,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,11013,0)
 ;;=788.20^^64^692^63
 ;;^UTILITY(U,$J,358.3,11013,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11013,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,11013,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,11013,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,11014,0)
 ;;=112.2^^64^692^66
 ;;^UTILITY(U,$J,358.3,11014,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11014,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,11014,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,11014,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,11015,0)
 ;;=600.01^^64^692^5
 ;;^UTILITY(U,$J,358.3,11015,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11015,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,11015,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,11015,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,11016,0)
 ;;=600.10^^64^692^40
 ;;^UTILITY(U,$J,358.3,11016,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11016,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,11016,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,11016,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,11017,0)
 ;;=585.9^^64^692^8
 ;;^UTILITY(U,$J,358.3,11017,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11017,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,11017,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,11017,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,11018,0)
 ;;=788.64^^64^692^59
 ;;^UTILITY(U,$J,358.3,11018,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11018,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,11018,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,11018,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,11019,0)
 ;;=788.65^^64^692^52
